Aarti Drugs has received approval to make investment in equity shares of Pinnacle Life Science (Pinnacle), wholly owned subsidiary of the company, upto an aggregate value of Rs 10.00 crore, by way of subscription to the rights issue. The company is interested in proposed transaction only to the extent of its shareholding in the Pinnacle. The investment proceeds will be used by Pinnacle for financing the cost towards expansion/capex plan and other general corporate purpose.
The Finance & Investment Committee of the company at its meeting held on March 07, 2026, has approved the same.
Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1792.45 |
| Dr. Reddys Lab | 1272.50 |
| Cipla | 1390.90 |
| Zydus Lifesciences | 1090.90 |
| Lupin | 2277.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: